AHF: Gilead's 'Obscene' $180M Payday for CEO Fuels Shareholder Resolution on Compensation

... and a vocal critic of runaway drug pricing and drug profiteering, today criticized Gilead Sciences , the leading HIV/AIDS drug maker, and its CEO John Martin for continuing their practice of pillaging U.S. taxpayers as a means to fund the company's ...

http://ift.tt/Oy3Q1y